What to anticipate for Netflix's earnings, which will be released after the market closes.
- Netflix is due to report third-quarter earnings after the closing bell Thursday.
- According to LSEG, Wall Street anticipates earnings per share of $5.12 and revenue of $9.76 billion.
- Executives will hold a call with analysts at 4:45 p.m. ET.
After the closing bell on Thursday, Los Angeles will release its third-quarter earnings report.
The company's advertising-supported business model, upcoming live sporting events, and the continued impact of its password crackdown on subscriber numbers will be closely monitored by Wall Street.
Netflix will no longer report subscriber data to shareholders, as it will now focus on revenue and other financial metrics as performance indicators.
Here's what Wall Street expects for the company's most recent quarter:
- Earnings per share: $5.12, according to LSEG
- Revenue: $9.76 billion, according to LSEG
- Paid memberships: 282.15 million, according to StreetAccount
Some Wall Street analysts predict that Netflix will soon announce price hikes due to the expected flat active subscriber numbers for the third quarter, as gains from its crackdown on password sharing start to taper off.
Both Dan Salmon of New Street Research and Benjamin Swinburne of Morgan Stanley predicted price increases in their recent research notes to investors.
The company's stock had increased by 44% year to date and 95% over the past 12 months as of Wednesday's close.
This is a breaking news story. Please check back for updates.
Business News
You might also like
- SpaceX's Starship is grounded by the FAA after a mid-flight explosion, causing property damage on Turks and Caicos.
- The unparalleled women's basketball league commences on Friday. Discover all the details here.
- PepsiCo faces allegations of price discrimination from the FTC, which claims it is increasing costs for consumers.
- The imposition of tariffs by Trump has prompted China to accelerate the shipment of goods to the US.
- Medicare drug price negotiations include Ozempic in the next round. Here are the 15 medications.